John Ellerton

5.4k citations
30 papers · 3.4k · 2 hit papers · h-index 18

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 5
    • Lung Cancer Research Studies 5
    • Cancer Treatment and Pharmacology 2
    • Bladder and Urothelial Cancer Treatments 9
    • Urinary and Genital Oncology Studies 6

John Ellerton

29 papers receiving 3.3k citations

John Ellerton's Hit Papers

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial 2017 · 437 citations
4370+8+16Years since publication4008001.2k

Peers

John Ellerton
Comparison fields: 5 of 99
  • Hematology 1.3k
  • Oncology 1.1k
  • Genetics 341
  • Cancer Research 328
  • Molecular Biology 975
Replace Karel A. Dicke with:
Karel A. Dicke United States
Dimitriοs Mavroudis Greece
Catherine Spier United States
Ajay K. Nooka United States
Hani Hassoun United States
Stephen H. Petersdorf United States
Stig Lenhoff Sweden
Kenan Onel United States
Luciano J. Costa United States
Rachid Baz United States
John Ellerton relative to Karel A. Dicke United States Karel A. Dicke's profile →
Citations per field
00.5×10.3×
Karel A. Dicke · 1×
Citations per year

Countries citing papers authored by John Ellerton

Since Specialization
Citations

This map shows the geographic impact of John Ellerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ellerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ellerton more than expected).

Fields of papers citing papers by John Ellerton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ellerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ellerton. The network helps show where John Ellerton may publish in the future.

Co-authors

The 25 scholars most cited alongside John Ellerton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Ellerton Line = papers co-authored together John Ellerton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
Hit paper breakdown →
20021342
2 1994454
3
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Hit paper breakdown →
2017437
4 2002323
5 2005129
6 201092
7 199584
8
Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group.
198080
9 199376
10 202063
11 200840
12 199933
13 201729
14 199329
15 201724
16 199120
17 201618
18 201717
19 199215
20 197914

About John Ellerton

John Ellerton is a scholar working on Oncology, Surgery, Hematology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 30 papers that have together received 3.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (5 papers), Acute Myeloid Leukemia Research (4 papers), Renal cell carcinoma treatment (2 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (1.1k citations), Genetics (341 citations), Cancer Research (328 citations) and Molecular Biology (975 citations). John Ellerton has collaborated with scholars based in United States, Belgium and South Korea. Frequent co-authors include Charles A. Schiffer, Carlos M. DeCastro, Rosalie Odchimar-Reissig, Richard A. Larson, Lewis R. Silverman, Bayard L. Powell, Jimmie C. Holland, James F. Holland, Erin P. Demakos and Alice B. Kornblith. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Blood and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact